The Centers for Medicare & Medicaid Services (CMS) has issued revised instructions and templates for prescription drug data collection (RxDC) reporting for 2022, required under the Consolidated Appropriations Act, 2021. The RxDC reporting deadline for the 2022 reference year is June 1, 2023.
As background, insurance companies and employer-sponsored group health plans must annually submit information about prescription drugs and healthcare spending to CMS. The first reports (which included information from 2020 and 2021 reference years) were due by January 31, 2023.
Employer plan sponsors will want to make sure that they and their third-party administrators, pharmacy benefit managers and carriers are using the revised reporting instructions when completing the RxDC reporting for the 2022 reference year.
| Title | File Type | File Size |
|---|---|---|
| Insider April 2023 | .2 MB |
